Recovery characteristics of patients receiving either sugammadex or neostigmine and glycopyrrolate for reversal of neuromuscular block: A randomised controlled trial
Anaesthesia Dec 12, 2017
Paech MJ, et al. - Researchers sought to compare the recovery characteristics of patients receiving either sugammadex or neostigmine and glycopyrrolate for reversal of neuromuscular block. Between groups, no significant difference was visible in 24-hour recovery scores. Notably, reversal with sugammadex vs neostigmine/glycopyrrolate did not attenuate postoperative nausea or vomiting.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries